This trial found that the Tan EndoGlide device caused less damage to cells during insertion of a donor corneal graft, as indicated by reduced cell loss at follow-up 1 year later, compared to the Busin glide.
2 Primary · 1 Secondary · Reporting Duration: 1 year
42 Total Participants · 2 Treatment Groups
Primary Treatment: Use of the Tan EndoGlide to insert donor graft · No Placebo Group · N/A
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: